Aldeyra Therapeutics, Inc. (ALDX) News

Latest headlines that mention ALDX, newest first · each headline opens the original publisher

ALDX quote

Last price: $0.68
Day change: +2.77%
Next earnings: 2026-11-04

Quote & chart Expected move Insider trading IV rank history

ALDX headlines

latest coverage

Not much coverage yet. ALDX has appeared in only a few headlines lately; new stories show up here as publishers cover it.

Seeking Alpha News 20d ago

Aldeyra Therapeutics, Inc. (ALDX) Discusses FDRR and FDA Review Process for Reproxalap in Dry Eye Disease - Slideshow

General T2ALDX

Seeking Alpha News 20d ago

Aldeyra Therapeutics, Inc. (ALDX) Discusses FDRR and FDA Review Process for Reproxalap in Dry Eye Disease Transcript

General T2ALDX

Seeking Alpha 21d ago

Aldeyra Therapeutics to appeal FDA rejection of dry eye disease drug reproxalap

General T2ALDX

Seeking Alpha News 3mo ago

Aldeyra Therapeutics: What Comes Next After Reproxalap's Third CRL

General T2ALDX

Investing.com 4mo ago

Form 4 Aldeyra The For: 11 June

General T3ALDX

Investing.com 4mo ago

Aldeyra appoints Darlene Deptula-Hicks to board of directors

General T3ALDX

ALDX news alerts

Get an alert by email or push when a new headline mentions ALDX.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.